Compare Stocks

Dajin Lithium Corp., together with its subsidiaries, primarily engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. It explores for lithium, potash, and boron minerals. The company holds a 100% interest in Teels Marsh Project that covers 403 placer mineral claims covering an area of approximately 3,202 hectares located in the Teels Marsh valley of Mineral County, Nevada; and Alkali Lake project, which includes 62 placer mineral claims situated in the Alkali Spring valley of Esmeralda county, Nevada. It also holds 49% interests in the Salinas Grandes Salar project that covers an area of 93,000 hectares located in the Jujuy province, Argentina. The company was formerly known as Dajin Resources Corp. and changed its name to Dajin Lithium Corp. in January 2020. Dajin Lithium Corp. was incorporated in 1987 and is based in Vancouver, Canada.

Goodrich Corporation (Goodrich) is a supplier of aerospace components, systems and services to the commercial and general aviation airplane markets. Goodrich also is a supplier of systems and products to the defense and space markets. Its business is conducted globally with manufacturing, service and sales undertaken in various locations worldwide. Goodrich's operates in three business segments: the Actuation and Landing Systems segment, the Nacelles and Interior Systems segment and the Electronic Systems segment. Its key products include actuation systems, landing gear, aircraft wheels and brakes, nacelles, interiors, engine control systems, intelligence surveillance and reconnaissance systems, sensor systems and power systems. On May 12, 2011, it acquired Microtecnica S.r.l. On September 30, 2011, the Company acquired Winslow Marine Products Corporation. In July 2012, United Technologies Corporation acquired Goodrich.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

The Global X S&P 500 Tail Risk ETF (XTR) is an exchange-traded fund that is based on the Cboe S&P 500 Tail Risk index. The fund tracks an index of the S&P 500 stocks and aims to protect the fund from significant negative movements or tail risk by purchasing quarterly Index put options. XTR was launched on Aug 25, 2021 and is managed by Global X.